Genes Patent
- All
- News
-
Australian Court Rules Cancer Gene Patent Invalid
- Wednesday October 7, 2015
- World News | Agence France-Presse
An Australian cancer survivor today triumphed in a landmark challenge against medical research companies, with the country's top court ruling they could not patent a gene linked to breast cancer.
- www.ndtv.com
-
US top court says naturally occurring human DNA can't be patented
- Thursday June 13, 2013
- World News | Reuters
The U.S. Supreme Court on Thursday ruled partially for Myriad Genetics Inc on the closely watched issue of whether human genes can be patented, deciding synthetically produced genetic material can be patented but naturally occurring DNA cannot.
- www.ndtv.com
-
Can human genes be patented? US court to decide
- Monday April 15, 2013
- World News | Associated Press
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian cancer and the multi-billion dollar medical and biotechnology business.
- www.ndtv.com
-
Australian Court Rules Cancer Gene Patent Invalid
- Wednesday October 7, 2015
- World News | Agence France-Presse
An Australian cancer survivor today triumphed in a landmark challenge against medical research companies, with the country's top court ruling they could not patent a gene linked to breast cancer.
- www.ndtv.com
-
US top court says naturally occurring human DNA can't be patented
- Thursday June 13, 2013
- World News | Reuters
The U.S. Supreme Court on Thursday ruled partially for Myriad Genetics Inc on the closely watched issue of whether human genes can be patented, deciding synthetically produced genetic material can be patented but naturally occurring DNA cannot.
- www.ndtv.com
-
Can human genes be patented? US court to decide
- Monday April 15, 2013
- World News | Associated Press
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian cancer and the multi-billion dollar medical and biotechnology business.
- www.ndtv.com